BRIEF-Mbx Biosciences Prices Its IPO Of 10.2 Mln Shares At $16.00 Per Share-March 2024-www.financetom.com

BRIEF-Mbx Biosciences Prices Its IPO Of 10.2 Mln Shares At $16.00 Per Share

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Mbx Biosciences Prices Its IPO Of 10.2 Mln Shares At $16.00 Per Share

Sep 13, 2024 2:06 PM

Sept 12 (Reuters) -

* MBX BIOSCIENCES ANNOUNCES PRICING OF INITIAL PUBLIC

OFFERING

* MBX BIOSCIENCES - PRICING OF ITS IPO OF 10,200,000 SHARES

OF ITS

COMMON STOCK AT A PRICE TO PUBLIC OF $16.00 PER SHARE

Source text for Eikon:

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： PureTech Health Chair Raju Kucherlapati Steps Down; Interim Chair Named

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

PureTech Health Chair Raju Kucherlapati Steps Down; Interim Chair Named

Jul 8, 2025

01:13 PM EDT, 07/08/2025 (MT Newswires) -- PureTech Health ( PRTC ) said Tuesday that Raju Kucherlapati, has stepped down as chair and member of the board. The company said it has appointed Sharon Barber-Lui, who currently chairs PureTech's audit committee, as interim chair. She will work with the nominating committee to identify a permanent chair and engage shareholders on...